Christopher Hoimes
Impact in
Papers in
- Co-authors
- Sandy Srinivas (19 shared papers)Terence W. Friedlander (14 shared papers)Nicholas J. Vogelzang (4 shared papers)Jonathan E. Rosenberg (24 shared papers)Daniel P. Petrylak (26 shared papers)Peter H. O’Donnell (12 shared papers)Thomas W. Flaig (26 shared papers)Efstathios Karathanasis (3 shared papers)
- Journals
- Journal of Clinical Oncology (66 papers)Annals of Oncology (20 papers)JAMA Oncology (2 papers)Journal of Computer Assisted Tomography (2 papers)Future Oncology (2 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Christopher Hoimes
123 papers receiving 3.1k citations
Christopher Hoimes's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.3k
- Surgery 1.3k
- Immunology 470
- Pulmonary and Respiratory Medicine 505
- Biomaterials 214
Countries citing papers authored by Christopher Hoimes
This map shows the geographic impact of Christopher Hoimes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Hoimes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Hoimes more than expected).
Fields of papers citing papers by Christopher Hoimes
This network shows the impact of papers produced by Christopher Hoimes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Hoimes. The network helps show where Christopher Hoimes may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Hoimes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2017 | 665 |
| 2 | Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer Hit paper breakdown → | 2022 | 173 |
| 3 | 2014 | 137 | |
| 4 | 2018 | 126 | |
| 5 | 2014 | 123 | |
| 6 | 2015 | 97 | |
| 7 | 2020 | 85 | |
| 8 | 2020 | 85 | |
| 9 | 2016 | 83 | |
| 10 | 2019 | 75 | |
| 11 | 2012 | 73 | |
| 12 | 2018 | 65 | |
| 13 | 2015 | 60 | |
| 14 | 2019 | 55 | |
| 15 | 2016 | 52 | |
| 16 | 2013 | 51 | |
| 17 | 2019 | 44 | |
| 18 | 2021 | 40 | |
| 19 | 2021 | 40 | |
| 20 | 2020 | 39 |
About Christopher Hoimes
Christopher Hoimes is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 130 papers that have together received 3.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (64 papers), Cancer Immunotherapy and Biomarkers (60 papers), Urinary and Genital Oncology Studies (30 papers), Prostate Cancer Treatment and Research (16 papers), CAR-T cell therapy research (10 papers), Cancer Research and Treatments (9 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Renal cell carcinoma treatment (8 papers). The work is most often cited by research in Oncology (1.3k citations), Surgery (1.3k citations), Immunology (470 citations), Pulmonary and Respiratory Medicine (505 citations) and Biomaterials (214 citations). Christopher Hoimes has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Sandy Srinivas, Terence W. Friedlander, Nicholas J. Vogelzang, Jonathan E. Rosenberg, Daniel P. Petrylak, Peter H. O’Donnell, Thomas W. Flaig, Efstathios Karathanasis, Yong Ben and Jingsong Zhang. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, JAMA Oncology, Journal of Computer Assisted Tomography and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.